Last updated 2026-06-18
- Raised $500k grant, Mar 2022
- Raised $2M funding round, Nov 2021
Total raised
$2.5M
Last: Grant 2022-03
Stage
Seed
Founded
2021
Headcount
4
HQ
Be'er Sheva, Israel
Sector
Health Tech & Life Sciences
About
Neuromagen Pharma is a pharmaceutical company developing a new class of innovative small molecules that activate telomerase reverse transcriptase (TERT), an enzyme that plays a major role in preventing cellular senescence.
The companys mission is to develop drugs to delay the onset and the progression of neurodegenerative diseases such as ALS and to improve and extend patients lives.
Neuromagen Pharma received FDA Orphan Drug Designation for its AGS-499 Drug Candidate to Slow the Progression of ALS (Amyotrophic Lateral Sclerosis).
Funding history · 2 rounds · $2.5M total
2022-03
Grant
$500K
2021-11
$2.0M
Q&A
- What is Neuromagen Pharma's primary focus?
- Neuromagen Pharma is a pharmaceutical company developing novel small molecules to activate telomerase reverse transcriptase (TERT) for neurodegenerative diseases like ALS.
- When was Neuromagen Pharma founded?
- Neuromagen Pharma was founded in May 2021.
- How many employees does Neuromagen Pharma currently have?
- Neuromagen Pharma has 1-10 employees.
- What is the total amount of funding Neuromagen Pharma has raised to date?
- Neuromagen Pharma has raised a total of $2,500,000.
- Has Neuromagen Pharma received any significant designations for its drug candidates?
- Yes, Neuromagen Pharma received FDA Orphan Drug Designation for its AGS-499 drug candidate, aimed at slowing the progression of ALS (Amyotrophic Lateral Sclerosis).
- Who are the co-founders of Neuromagen Pharma?
- The co-founders of Neuromagen Pharma are Gil Ben-Menachem, who serves as Co-founder & CEO, and Esther Priel, who serves as Founder, CEO & CSO.
- What was Neuromagen Pharma's most recent funding round?
- Neuromagen Pharma's most recent funding round was a Grant in March 2022, which raised $500,000 from IIA.
- What is the current product stage of Neuromagen Pharma?
- Neuromagen Pharma is currently in the R&D product stage.
Team · 2
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCellsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
pharmaceuticalsamyotrophic-lateral-sclerosis-alsdegenerative-diseasesdrug-developmentcells
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | neuromagen.com/ |
|---|---|
| linkedin.com/company/80297359 |
Identifiers & details
| Founded | 2021-5 |
|---|---|
| Employees (exact) | 4 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | neuromagen.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|